The Knowledge Hub

Endocrine research frequently targets the hypothalamic-pituitary-somatotropic axis to map regulatory pathways. Growth hormone-releasing hormone (GHRH) operates as the primary stimulatory ligand here, originating in the hypothalamus before interacting with anterior pituitary cells. While native GHRH…

Studying growth hormone-releasing hormone (GHRH) analogues requires precise control over experimental variables during cellular assays. Among these analogues, tesamorelin features unique structural modifications that alter its stability and receptor affinity in vitro. When designing large-scale lab…

Modified analogues of endogenous Growth Hormone-Releasing Hormone (GHRH), such as tesamorelin, permit investigators to isolate specific endocrine mechanisms during in-vitro cellular assays. This 44-amino acid peptide features a distinct structural alteration at its N-terminus: the covalent attachmen…

Mitochondrial biology has expanded significantly over the past two decades. Rather than acting solely as cellular energy producers, mitochondria function as dynamic signalling organelles communicating physiological data to the nucleus. This mitochondrial retrograde signalling maintains cellular home…

Cellular biology increasingly recognises mitochondria not merely as metabolic engines, but as active signalling hubs communicating stress status directly to the nucleus. This retrograde signalling pathway relies on mitochondrial-derived peptides (MDPs) encoded within the organelle's own genome. Amo…